October 6, 2022 | 12:00 – 1:00 PM Eastern / 9:00 – 10:00 AM Pacific
The session, hosted by the International Society for Pharmacoepidemiology (ISPE), will begin with a brief introduction of the topic and the speakers (moderators, 4-5 min, Drs. Andrew Zullo & Daniela Moga) followed by presentations to address:
- The existing deprescribing landscape (including existing deprescribing networks throughout the world), current initiatives in clinical and implementation deprescribing research, and the need to incorporate real-world data and observational studies (Dr. Caroline Sirois, 12 min)
- Recent efforts in operationalizing key variables needed for deprescribing studies using routinely generated healthcare data, including harmonizing measures across different healthcare systems and data types: finding from the US Deprescribing Research Network Data Harmonization Workgroup (Dr. Sascha Dublin, 12 min)
- Challenges and opportunities in using pharmacoepidemiologic approaches in deprescribing research (Dr. Anton Pottegård, 12 min)
The session will conclude with a call for methodology development and finding ways for data integration to facilitate observational deprescribing research under a causal framework (moderators, 5 min) followed by a Q&A session.
Co-sponsored by the US Deprescribing Research Network (USDeN) and Australian Deprescribing Network (ADeN).